OR WAIT null SECS
August 09, 2019
The facility will support gene therapy production and continued development of PTC’s pipeline of investigational medicines.
August 07, 2019
An affiliate of the Permira funds has signed an agreement to purchase Cambrex in an approximately $2.4-billion transaction.
August 02, 2019
Much has changed in the bio/pharma industry over three decades. In this special feature, the editors take a trip down memory lane, highlighting some of the major happenings of the past 30 years.
August 01, 2019
Fujifilm has bought Biogen ApS’ Copenhagen facility for US$890 million.
July 17, 2019
Abcam has acquired the entire live cell line and lysates portfolio of gene-editing therapy developer, EdiGene.
June 17, 2019
The US Federal Trade Commission (FTC) has requested additional information from Roche and Spark Therapeutics regarding Roche’s pending $4.3-billion acquisition of Spark.
June 14, 2019
Dassault Systèmes, a provider of virtual universes to imagine sustainable innovations, has signed a definitive agreement to acquire Medidata Solutions in an all-cash transaction.
June 13, 2019
The companies will form a biometrics organization focused on delivering analytical solutions for drug development.
The acquisitions, totaling $50 million, are expected expand Aptar Pharma’s service offerings to support complex product development.
The acquisition will boost Merck’s pipeline for cancer, fibrosis, and autoimmune disease therapeutics.